Prospects for Alzheimer’s Disease Medicines
Alzheimer’s Disease is a leading cause of death in developed countries. However, uniquely amongst leading causes of death, Alzheimer’s Disease lacks medicines to successfully treat or even slow down illness progression. However, two new potential medicines have very recently demonstrated effectiveness in treating this disease. This paper will explore:
What is Alzheimer’s Disease
Why developing Alzheimer’s Disease medicines has been so difficult
The relative benefits and risks of these two new medicines
The broad impact these two medicines may have on future longevity and residential care utilisation
The prospects for additional new medicines to be developed.
This webinar will be a summary of the paper Prospects for Alzheimer's Disease Medicines produced by Ivor O'Shea. You can access and read the paper here.